即期假体乳房重建中无菌与无菌冻干脱细胞真皮基质的比较
本研究纳入2039例即期假体乳房重建(1285例患者),比较冻干与即用型脱细胞真皮基质。冻干组假体取出率18.0%显著高于即用型组12.0%(p=0.0036),手术部位感染等并发症无显著差异;多因素回归显示冻干组取出 odds 更高(OR 1.570,p=0.0161),吸烟和BMI也是取出独立预测因素。
要点
- 即用型脱细胞真皮基质假体取出率低于冻干型(12.0% vs 18.0%,p=0.0036)。
- 两组手术部位感染、伤口裂开、皮瓣坏死、血清肿、血肿无显著差异。
- 吸烟(OR 2.809)和BMI(OR 1.054)是假体取出的独立预测因素。
核心结论
- 即用型无菌脱细胞真皮基质总体安全性与冻干型相当,且假体取出率更低。
研究设计与样本
- 回顾性队列分析1285例患者共2039例即期假体乳房重建,冻干组612例(910侧乳房),即用型组673例(1129侧乳房)。
- 进行了先验效能分析,并使用逻辑回归模型控制潜在混杂因素。
主要发现
- 冻干组假体取出率18.0%显著高于即用型组12.0%(p=0.0036)。
- 两组手术部位感染、伤口裂开、乳房切除皮瓣坏死、血清肿和血肿无显著差异。
- 多因素回归中,冻干组对比即用型组手术部位感染OR 1.064(p=0.7455),假体取出OR 1.570(p=0.0161)。
- 吸烟(OR 2.809,p=0.0002)和BMI(OR 1.054,p<0.0001)是假体取出的独立预测因素。
临床怎么用
- 在即期假体乳房重建中可优先考虑即用型无菌脱细胞真皮基质以降低假体取出风险。
- 术前应评估并控制吸烟和BMI等可干预的假体取出危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sterile ready-to-use acellular dermal matrix, introduced as an alternative to aseptic freeze-dried acellular dermal matrix for implant-based breast reconstruction, has been investigated in a limited number of studies. This study compared outcomes in implant-based breast reconstruction with ready-to-use and freeze-dried acellular dermal matrix. METHODS: The authors analyzed patients undergoing implant-based breast reconstruction with either freeze-dried or ready-to-use acellular dermal matrix, including demographics, clinical variables, and outcomes. An a priori power analysis was performed and logistic regression modeling was used to quantify the effect of acellular dermal matrix on outcomes while controlling for potential confounders. RESULTS: A total of 1285 consecutive patients undergoing 2039 immediate prosthetic breast reconstructions constituted the population: 612 (n = 910 breasts) with freeze-dried matrix and 673 (n = 1129 breasts) with ready-to-use acellular dermal matrix. The freeze-dried matrix cohort had a significantly higher rate of explantation compared with the ready-to-use matrix cohort (18.0 percent versus 12.0 percent; p = 0.0036), but surgical-site infection, wound dehiscence, mastectomy flap necrosis, seroma, and hematoma did not differ significantly between groups. On multivariate regression, patients undergoing reconstruction with freeze-dried matrix, compared to ready-to-use matrix, did not have higher odds of experiencing surgical-site infections (OR, 1.064; p = 0.7455), but did have higher odds of explantation (OR, 1.570; p = 0.0161). Tobacco use (OR, 2.809; p = 0.0002) and body mass index (OR, 1.054; p < 0.0001) were also independent predictors of explantation. CONCLUSION: Immediate implant-based breast reconstruction with sterile ready-to-use acellular dermal matrix has a comparable overall safety profile and a lower rate of prosthetic explantations compared with aseptic freeze-dried acellular dermal matrix. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Parikh RP, Brown GM, Sharma K, et al. Immediate Implant-Based Breast Reconstruction with Acellular Dermal Matrix: A Comparison of Sterile and Aseptic AlloDerm in 2039 Consecutive Cases. Plast Reconstr Surg. 2018. PMID: 30204676. doi:10.1097/PRS.0000000000004968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。